Back Pain

Epidemiology and Anatomy

Back pain is the second most common reason for physician visits in the United States, trailing only upper respiratory tract infections. It is one of the most consequential conditions in all of medicine — not because it is lethal, but because of its staggering prevalence and economic footprint. 80% of adults experience at least one significant episode of back pain during their lifetime. Annual point prevalence reaches approximately 25% of the adult population, and the condition costs the US healthcare system and economy over $100 billion per year when direct medical expenses and lost workplace productivity are combined. Globally, low back pain is the leading cause of years lived with disability, outranking all other conditions in that metric.

The Global Burden of Disease study counted 619 million people with low back pain worldwide in 2020, and projects 843 million by 2050. Low back pain remains the leading cause of years lived with disability, and 38.8% of that disability was attributed to three risk factors: work factors, smoking and high body weight.

Understanding the anatomy is essential to understanding back pain. The vertebral column consists of 33 vertebrae: 7 cervical (C1–C7), 12 thoracic (T1–T12), 5 lumbar (L1–L5), 5 sacral (fused into the sacrum), and 4 coccygeal. The lumbar spine (L1–S1) is by far the most commonly affected region, owing to its role in bearing the full weight of the upper body and its range of flexion/extension movement.

Intervertebral discs sit between each pair of adjacent vertebrae. Each disc has an inner nucleus pulposus — a gelatinous, hydrated core — enclosed by concentric rings of fibrocartilage called the annulus fibrosus. Discs function as shock absorbers and allow spinal motion. They are avascular after childhood, receiving nutrients entirely by diffusion from adjacent vertebral endplates. This limited blood supply makes discs susceptible to degeneration with age, physical load, smoking, and dehydration.

The key lumbar nerve roots and their clinical correlates are critical for localizing pathology on examination:

• L4 root: knee extension (quadriceps), patellar (knee-jerk) reflex
• L5 root: dorsiflexion and big toe extension (extensor hallucis longus); no reliable reflex to test
• S1 root: plantar flexion (gastrocnemius/soleus), Achilles tendon reflex

Back to Table of Contents

Mechanical Causes (90% of Low Back Pain)

Mechanical back pain — pain arising from spinal structures without a systemic or visceral cause — accounts for roughly 90% of all back pain presentations. Within this broad category, several distinct entities are recognized.

Nonspecific Low Back Pain

The most common presentation. No identifiable structural cause is found on clinical examination or imaging. The underlying substrate is typically muscle strain or ligament sprain from an acute mechanical event — lifting, twisting, or prolonged posture. A 2003 systematic review of 15 studies (Pengel) found that pain fell by an average of 58% within the first month, with further improvement until about three months; after that, pain and disability stayed almost level, and in many people they are ongoing. Recurrence is common: 73% of people had at least one recurrence within 12 months, and a subset transitions to chronic pain.

Disc Herniation

When the nucleus pulposus extrudes through a tear in the annulus fibrosus, it can compress adjacent nerve roots and cause radiculopathy (nerve root pain). The most commonly affected levels are L4–L5 (compressing the L5 root) and L5–S1 (compressing the S1 root). The classic syndrome is sciatica: unilateral leg pain that exceeds back pain in intensity, radiating from the buttock through the posterior thigh, calf, and into the foot — typically in a dermatomal distribution.

The Straight Leg Raise (SLR) test is the most clinically useful maneuver: with the patient supine, the examiner raises the extended leg passively. Reproduction of the patient's radicular leg pain between 30° and 70° of hip flexion is a positive test, with sensitivity approximately 91% but specificity only 26% for L4–L5 or L5–S1 disc herniation. The crossed SLR — raising the contralateral leg reproduces pain in the symptomatic leg — is far more specific (approximately 88%) though less sensitive (about 29%). These pooled figures come from a 2000 review of 11 surgical studies of the test (Devillé). In plain terms, a negative straight leg raise makes a herniated disc less likely, while a positive one on its own proves little; the review noted that every included study was a surgical case series. 90% of disc herniations resolve without surgery over 6–12 weeks with conservative care.

Spinal Stenosis

Degenerative narrowing of the spinal canal, lateral recesses, or neural foramina causes compression of the cauda equina or individual nerve roots. The hallmark presentation is neurogenic claudication: bilateral leg pain, weakness, and numbness that is provoked by walking or standing and relieved by sitting or forward flexion (flexion increases canal diameter). The classic "shopping cart sign" — the patient who leans forward on a shopping cart and can walk much farther — reflects this positional physiology. Spinal stenosis affects older adults and has a degenerative etiology. Magnetic resonance imaging (MRI) confirms the diagnosis. The SPORT spinal stenosis study (Weinstein, N Engl J Med 2008) enrolled 289 people in a randomized group and 365 in an observational group. In the randomized comparison, where many people crossed over between treatments, surgery gave a significant advantage only on the bodily-pain scale, with no significant difference in physical function or the Oswestry disability score. In the combined as-treated analysis, people who had decompressive surgery improved significantly more on all main outcomes by 3 months, and the difference held at 2 years.

Spondylolisthesis

Forward displacement of one vertebra over the one below it. L4 on L5 is the most common level. Degenerative spondylolisthesis occurs in older adults through facet joint and disc degeneration. Isthmic spondylolisthesis results from a pars interarticularis stress fracture and is most common in young athletes subjected to repetitive hyperextension — gymnasts, football linemen, wrestlers. Severity is graded I through IV based on the degree of slip: Grade I (1–25%), Grade II (26–50%), Grade III (51–75%), Grade IV (>75%).

Facet Joint Pain

Osteoarthritis of the posterior facet (zygapophyseal) joints produces a characteristic pattern of bilateral dull aching low back pain worsened by extension and rotation, typically without significant radiculopathy. Diagnosis is confirmed with medial branch nerve blocks; if two diagnostic blocks produce >50–80% pain relief, radiofrequency ablation (neurotomy) of the medial branch nerves can provide 6–12 months of meaningful relief.

Back to Table of Contents

Red Flags — Serious Causes Requiring Urgent Evaluation

While mechanical back pain is benign and self-limited in the vast majority, a small but critically important subset of presentations signals serious underlying pathology. Recognizing these "red flags" and acting promptly can prevent irreversible harm.

Cauda Equina Syndrome — A True Emergency

Cauda equina syndrome (CES) results from compression of the cauda equina nerve roots (the bundle of lumbosacral roots below the conus medullaris at L1). It demands immediate recognition and surgical decompression. The classic constellation of red flags includes:

• Saddle anesthesia — numbness or altered sensation in the perineum, inner thighs, and genitalia (the area that would contact a saddle)
• Bladder dysfunction — urinary retention is the most common and ominous feature; post-void residual >200 mL is a reliable marker; overflow incontinence may develop
• Bowel dysfunction — fecal incontinence, loss of anal sphincter tone
• Bilateral lower extremity weakness
• Sexual dysfunction

Common causes include massive central disc herniation (L4–L5 most frequently), epidural abscess, epidural hematoma, and spinal tumor. CES is a surgical emergency: standard care is emergency magnetic resonance imaging and surgical decompression within 24–48 hours. Delay beyond this window significantly worsens the prognosis for recovery of bladder and bowel function, which may become permanent.

Malignancy

Back pain that is the presenting symptom of spinal metastasis or primary spinal tumor carries characteristic features: history of known cancer, unrelenting pain at rest and at night that does not improve with any position change, unexplained weight loss, and age over 50. The spine is the most common site of bony metastases. The primary cancers most likely to metastasize to bone in descending frequency are: lung, breast, prostate, kidney, and thyroid. Workup includes bone scan or whole-spine magnetic resonance imaging with contrast.

Vertebral Osteomyelitis

Infection of the vertebral body or disc space presents with fever, severe localized back pain, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Risk factors include intravenous drug use, immunosuppression, diabetes mellitus, and recent spinal procedure. Contiguous spread from a psoas abscess is a recognized mechanism. Staphylococcus aureus is the most common pathogen. Workup requires magnetic resonance imaging with contrast and blood cultures before initiating antibiotics. Biopsy may be required to identify the organism.

Vertebral Compression Fracture

Sudden onset of severe, well-localized mid-thoracic or lumbar pain following minimal trauma — or no trauma at all — in a patient with osteoporosis, postmenopausal status, chronic corticosteroid use, or underlying malignancy suggests vertebral compression fracture. Plain X-ray demonstrates vertebral height loss; MRI with a short tau inversion recovery (STIR) sequence distinguishes acute from chronic fractures and reveals marrow edema in acute injury.

Back to Table of Contents

Thoracic and Referred Back Pain

Not all back pain originates in the spine. Several visceral and vascular emergencies present with back pain as a dominant or sole symptom. Failure to consider these diagnoses in the appropriate clinical context is a serious diagnostic error.

• Aortic Aneurysm / Aortic Dissection: A tearing or ripping back pain of abrupt onset, often radiating to the anterior chest or interscapular region, in a patient with a history of hypertension or known aortic disease is an emergency until proven otherwise. Computed tomography (CT) angiography of the chest, abdomen, and pelvis is the imaging of choice; waiting for magnetic resonance imaging delays the diagnosis.
• Acute Pancreatitis: Epigastric pain radiating to the mid-back in a "band around the waist" pattern, often associated with nausea, vomiting, and elevated serum lipase. Causes include gallstones and heavy alcohol use.
• Pyelonephritis / Nephrolithiasis: Flank pain with costovertebral angle (CVA) tenderness is the hallmark. Pyelonephritis presents with fever and dysuria; nephrolithiasis with colicky, severe unilateral pain and hematuria. Both may be mistaken for musculoskeletal back pain.
• Posterior Penetrating Peptic Ulcer: Chronic mid-back pain that is meal-related and associated with epigastric symptoms; occurs when a gastric or duodenal ulcer erodes posteriorly toward the pancreas.
• Retroperitoneal Pathology: Lymphoma, retroperitoneal fibrosis, and inferior vena cava thrombosis can all cause dull, persistent back pain without a musculoskeletal explanation. Computed tomography with contrast of the abdomen and pelvis is the primary imaging modality.

Back to Table of Contents

Inflammatory Back Pain — Ankylosing Spondylitis and Spondyloarthritis

A clinically important minority of patients with chronic back pain has an inflammatory arthritis of the spine and sacroiliac joints rather than a mechanical problem. Distinguishing inflammatory from mechanical back pain early is critical because the treatment differs fundamentally, and delayed diagnosis can result in irreversible spinal fusion.

The Inflammatory Back Pain Pattern

Inflammatory back pain has a characteristic profile that contrasts sharply with mechanical pain:

• Morning stiffness lasting more than 30 minutes (mechanical pain has brief stiffness) — the cut-off used in the 2006 Berlin inflammatory back pain criteria (Rudwaleit), where any 2 of 4 features (this stiffness, improvement with exercise but not rest, waking in the second half of the night, alternating buttock pain) picked out ankylosing spondylitis with a sensitivity of 70.3% and a specificity of 81.2%
• Improves with activity and exercise (mechanical pain typically worsens)
• Does NOT improve with rest
• Onset before age 40
• Nocturnal awakening — the patient is awakened by back pain in the second half of the night and must get up to move
• Alternating buttock pain — shifts from one buttock to the other, reflecting sacroiliac joint inflammation
• Dramatic response to nonsteroidal anti-inflammatory drugs (NSAIDs) — relief within 24–48 hours at full dose

Ankylosing Spondylitis (AS) and Axial Spondyloarthropathy (AxSpA)

Ankylosing Spondylitis is the prototypical inflammatory back pain condition. It is strongly associated with human leukocyte antigen-B27 (present in ~90% of ankylosing spondylitis patients vs. 6–8% of the general population). The disease begins in the sacroiliac joints and ascends. Over years, progressive ossification of spinal ligaments and discs produces the classic "bamboo spine" appearance on X-ray. Extraarticular manifestations include anterior uveitis, psoriasis, inflammatory bowel disease, and aortic regurgitation.

Biologic therapies — tumor necrosis factor (TNF) inhibitors (etanercept, adalimumab, infliximab) and interleukin-17 (IL-17) inhibitors (secukinumab, ixekizumab) — have transformed the management of moderate-to-severe ankylosing spondylitis.

Sacroiliitis Imaging

Early sacroiliitis is the hallmark of AxSpA and the key diagnostic target:

• Plain X-ray: Changes appear late in the disease course — erosion, sclerosis, and eventual fusion of the sacroiliac joints. Normal X-rays do not exclude early disease.
• Magnetic resonance imaging of sacroiliac joints with STIR sequence: The gold standard for detecting early active inflammation. Bone marrow edema on STIR MRI may be present years before X-ray changes appear and is a criterion for non-radiographic AxSpA. This is the single most important investigation when inflammatory back pain is suspected in a young patient with normal X-rays.

Back to Table of Contents

Diagnostic Approach

The cornerstone of evaluating back pain remains the clinical history and physical examination. A focused assessment identifies the pattern of pain (mechanical vs. inflammatory vs. referred), localizes neurological deficits, and screens for red flags. No imaging substitutes for this clinical synthesis.

When NOT to Image — The Critical Default

Routine imaging is not indicated in the first 4–6 weeks of uncomplicated low back pain without red flags. This recommendation is supported by robust evidence and endorsed by every major guideline (the American College of Physicians (ACP), the American College of Radiology (ACR) and the UK National Institute for Health and Care Excellence (NICE)). The reasons are:

• Magnetic resonance imaging findings of disc degeneration and disc bulges are extremely common in asymptomatic adults — prevalence exceeds 50% in people over age 40 with no back pain whatsoever
• Imaging findings do not correlate reliably with pain severity or disability
• Early routine imaging is associated with higher rates of surgery without improved outcomes, driven by incidental findings that prompt unnecessary intervention
• 70% of people who receive magnetic resonance imaging at 6 weeks show "abnormalities" that may be incidental to their current episode

When to Image

Imaging is appropriate in the presence of:

• Any red flag feature (cauda equina, malignancy, infection, fracture)
• Failure to improve after 4–6 weeks of appropriate conservative management
• Radiculopathy accompanied by objective motor deficit
• Suspected axial spondyloarthropathy (magnetic resonance imaging sacroiliac joints with STIR)
• Pre-operative planning
• Progressive neurological deficit

Imaging Modality Selection

• Magnetic resonance imaging (preferred): No ionizing radiation; excellent soft-tissue detail; best for disc, nerve root, spinal cord, bone marrow, and infection
• Computed tomography: Superior bone detail; preferred for fractures and post-surgical hardware evaluation; higher radiation dose
• X-ray: Limited utility for soft tissue; appropriate for acute trauma or spondylolisthesis grading
• Bone scan (technetium-99m): Whole-body screening for bony metastases, useful when spinal metastasis suspected

Back to Table of Contents

Evidence-Based Treatment

Acute Low Back Pain (<12 Weeks)

The foundational principle of acute low back pain management is that active movement produces better outcomes than rest. Bed rest worsens acute back pain — it leads to deconditioning, fear-avoidance, and prolonged disability. Staying as active as possible within pain tolerance is the standard advice in back-pain care.

The 2017 American College of Physicians guideline (built on trials published through 2016) states that most people with acute or subacute low back pain improve over time regardless of treatment. It recommends superficial heat (moderate-quality evidence), massage, acupuncture or spinal manipulation (low-quality evidence) as the first choice; if a drug is wanted, it lists nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants.

• Nonsteroidal anti-inflammatory drugs (first-line analgesic): Ibuprofen, naproxen, diclofenac. The American College of Physicians guideline lists them for acute pain and does not list acetaminophen. In the PACE trial (Lancet 2014), 1,652 people with new low back pain took acetaminophen (paracetamol) regularly, acetaminophen as needed, or a placebo for up to 4 weeks; median recovery took 17, 17 and 16 days, so acetaminophen did not speed recovery. The prescription NSAID labels state the lowest effective dose for the shortest duration. Risks include stomach and gut (gastrointestinal) bleeding (a proton pump inhibitor is sometimes given alongside for stomach protection when use is prolonged), cardiovascular effects in at-risk patients, and nephrotoxicity. Topical diclofenac gel offers local benefit with substantially lower systemic absorption.
• Muscle Relaxants: The U.S. Food and Drug Administration labels for cyclobenzaprine and methocarbamol cover acute, painful musculoskeletal conditions (the cyclobenzaprine label limits use to short periods, up to 2 or 3 weeks). Tizanidine is labelled for spasticity, and oral baclofen for spasticity from multiple sclerosis or spinal cord disease; the baclofen label states it is not indicated for muscle spasm from rheumatic disorders. Benefit is predominantly for muscle spasm. They are sedating, and the fall risk and anticholinergic effects weigh most in older adults.
• Heat (topical): Continuous low-level heat wraps are as effective as nonsteroidal anti-inflammatory drugs for acute lumbar strain in several trials. Safe, inexpensive, and widely available.
• Massage: Effective for acute and subacute nonspecific low back pain; moderate evidence for short-term pain reduction and functional improvement.
• Spinal Manipulation: Chiropractic or osteopathic manipulation produces moderate short-term benefit for acute nonspecific low back pain, comparable to nonsteroidal anti-inflammatory drugs in head-to-head trials. Risk of serious adverse events (cauda equina, arterial dissection) is extremely rare for lumbar manipulation.
• Opioids: For acute nonspecific low back pain, opioids provide marginal short-term analgesic benefit set against serious risks — dependence, addiction, opioid-induced hyperalgesia, cognitive effects, constipation, respiratory depression. There is no evidence of long-term benefit for nonspecific low back pain. In the OPAL trial (Lancet 2023), 347 adults with new low back or neck pain took a short course of an opioid (oxycodone-naloxone, for up to 6 weeks) or an identical placebo; at 6 weeks pain was no better on the opioid (mean score 2.78 versus 2.25 on placebo, on a 10-point scale, p=0.051), and constipation was more common (7.5% versus 3.5%). The American College of Physicians guideline does not list opioids for acute low back pain; for chronic low back pain it names tramadol (an opioid) or duloxetine as second-line drugs, and other opioids only for people who have not been helped by those treatments, after a discussion of the known risks.

Chronic Low Back Pain (>12 Weeks)

For chronic low back pain, the American College of Physicians guideline recommends starting with non-drug treatments: exercise, multidisciplinary rehabilitation, acupuncture, mindfulness-based stress reduction (moderate-quality evidence), tai chi, yoga, motor control exercise, progressive relaxation, electromyography biofeedback, low-level laser therapy, operant therapy, cognitive behavioral therapy or spinal manipulation (low-quality evidence). When these do not help enough, it lists nonsteroidal anti-inflammatory drugs first and tramadol or duloxetine second.

Chronic low back pain is managed with a multidisciplinary biopsychosocial approach that addresses physical, psychological, and social dimensions simultaneously. Single-modality treatment is inferior to combined programs.

• Cognitive Behavioral Therapy (CBT): The strongest evidence base for chronic low back pain. CBT targets fear-avoidance beliefs, pain catastrophizing, and kinesiophobia (fear of movement). It reduces disability and improves function even when pain intensity does not fully resolve.
• Supervised Exercise: Core stabilization, aerobic conditioning, McKenzie method (extension-based), yoga, and Pilates all have demonstrated efficacy. The specific exercise program matters less than consistency and supervision — adherence is the key determinant of outcome.
• Duloxetine: A serotonin-norepinephrine reuptake inhibitor with U.S. Food and Drug Administration (FDA) approval specifically for chronic musculoskeletal pain including chronic low back pain. Acts via descending noradrenergic pain modulation. Number needed to treat (NNT) approximately 10 for meaningful pain relief. Modest but real effect size.
• Gabapentinoids (Gabapentin, Pregabalin): Evidence for chronic nonspecific low back pain is weak; adverse effects (sedation, dizziness, weight gain, abuse potential) are significant. Multiple guidelines recommend against or caution against routine use for chronic low back pain.
• Epidural Steroid Injection (ESI): Transforaminal or interlaminar steroid injection provides 30–50% short-term (6–12 weeks) pain relief for radiculopathy due to disc herniation or foraminal stenosis. Epidural steroid injection is not indicated for nonspecific low back pain without radiculopathy. Repeat injections have diminishing returns; most guidelines recommend limiting to 3 per year.
• Acupuncture: Moderate evidence for short-term benefit in chronic low back pain; included in the American College of Physicians guideline as a nonpharmacologic option.
• Surgery: Reserved for patients with specific structural pathology (disc herniation, spinal stenosis with functional limitation, high-grade spondylolisthesis) who have failed at least 6–12 months of optimal conservative management (or sooner if progressive neurological deficit). Microdiscectomy for disc herniation has an 80–90% success rate in carefully selected patients. Decompressive laminectomy is the primary surgery for symptomatic spinal stenosis. Spinal fusion is indicated for instability, high-grade spondylolisthesis, and certain revision scenarios; outcomes are less predictable for fusion performed primarily for chronic pain without structural instability.

Back to Table of Contents

Chronic Pain Neuroscience and Prevention

Central Sensitization and the Transition to Chronic Pain

In a subset of patients, acute back pain transitions to a chronic pain state that is disproportionate to, or entirely independent of, residual tissue damage. The mechanism is central sensitization: pathological amplification of pain signaling within the dorsal horn of the spinal cord and the brain. Descending inhibitory pathways from the periaqueductal gray and rostral ventromedial medulla lose efficacy. The result is that pain no longer faithfully reports tissue damage — it has become a self-sustaining neurological phenomenon. Chronic pain, in this model, is a disease in itself, not merely a symptom of ongoing injury.

The fear-avoidance model explains the behavioral reinforcement of this process: pain catastrophizing ("this pain means something terrible is wrong") generates fear of movement (kinesiophobia), which leads to physical avoidance and deconditioning, which worsens pain sensitivity, which reinforces catastrophizing — a vicious cycle.

Pain Neuroscience Education (PNE)

PNE — explaining to patients the neuroscience of how chronic pain works — is one of the most evidence-supported psychological interventions for chronic low back pain. When patients understand that pain sensitivity can increase without corresponding tissue damage, that imaging findings are not necessarily meaningful, and that movement does not equal damage, catastrophizing decreases and function improves. PNE is most effective when combined with exercise.

Prevention

Back pain is not inevitable despite its extraordinary prevalence. Modifiable risk factors include:

• Physical inactivity: Regular moderate aerobic exercise and core strengthening are the most evidence-based preventive strategies. Sedentary individuals have substantially higher rates of back pain episodes and disability.
• Obesity: a 2010 meta-analysis of 33 studies (Shiri) found that obesity raised the odds of low back pain by about a third to a half (odds ratio 1.33 for back pain in the past year, 1.43 for chronic low back pain, and 1.53 for new back pain in cohort studies). Mechanical overload, altered spinal biomechanics, and systemic inflammation all contribute.
• Smoking: Nicotine causes microvascular ischemia that accelerates intervertebral disc degeneration. Smokers have higher rates of disc herniation, chronic low back pain, and pseudarthrosis (failed spinal fusion). Smoking is one of the three risk factors to which the Global Burden of Disease study attributed 38.8% of the disability from low back pain.
• Occupational and ergonomic factors: Ergonomic measures described include lifting with a hip hinge rather than lumbar flexion, standing desks to break up prolonged sitting, a monitor at eye level, and fewer sustained awkward postures. Some ergonomic advice puts a limit of about 30 minutes on continuous sitting before a short movement break, on the idea that brief movement interruptions reset lumbar muscle fatigue.
• Psychological factors: Workplace dissatisfaction, depression, and anxiety are stronger predictors of chronic back pain disability than the severity of initial injury. Addressing psychological wellbeing is part of genuine prevention.

Back to Table of Contents

Key Research Papers

1. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. "Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians." Ann Intern Med. 2017;166(7):514–530. — PubMed PMID: 28192789 · doi:10.7326/M16-2367
2. Deyo RA, Weinstein JN. "Low Back Pain." N Engl J Med. 2001;344(5):363–370. — Search PubMed · doi:10.1056/NEJM200102013440508
3. Weinstein JN, Tosteson TD, Lurie JD, et al. "Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial." JAMA. 2006;296(20):2441–2450. — PubMed PMID: 17119140 · doi:10.1001/jama.296.20.2441
4. Pengel LH et al. "Acute low back pain: systematic review of its prognosis." BMJ. 2003;327(7410):323. — PubMed PMID: 12907487 · doi:10.1136/bmj.327.7410.323
5. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. "Opioids compared to placebo or other treatments for chronic low-back pain." Cochrane Database Syst Rev. 2013;(8):CD004959. — PubMed PMID: 23983011 · doi:10.1002/14651858.CD004959.pub4
6. Kamper SJ et al. "Multidisciplinary biopsychosocial rehabilitation for chronic low back pain." Cochrane Database Syst Rev. 2014;(9):CD000963. — PubMed PMID: 25180773 · doi:10.1002/14651858.CD000963.pub3
7. Sieper J et al. "Ankylosing spondylitis: an overview." Ann Rheum Dis. 2002;61 Suppl 3:iii8–18. — PubMed PMID: 12381506 · doi:10.1136/ard.61.suppl_3.iii8
8. van Tulder M et al. "Exercise therapy for low back pain." Cochrane Database Syst Rev. 2000;(2):CD000335. — Search PubMed · doi:10.1002/14651858.CD000335
9. Waddell G, Burton AK. "Occupational health guidelines for the management of low back pain at work." Occup Med (Lond). 2001;51(2):124–135. — PubMed PMID: 11307688 · doi:10.1093/occmed/51.2.124
10. Koes BW et al. "Diagnosis and treatment of low back pain." BMJ. 2006;332(7555):1430–1434. — Search PubMed · doi:10.1136/bmj.332.7555.1430
11. Maher C et al. "Non-specific low back pain." Lancet. 2017;389(10070):736–747. — PubMed PMID: 27745712 · doi:10.1016/S0140-6736(16)30970-9
12. Foster NE et al. "Prevention and treatment of low back pain: evidence, challenges, and promising directions." Lancet. 2018;391(10137):2368–2383. — PubMed PMID: 29573872 · doi:10.1016/S0140-6736(18)30489-6
13. Weinstein JN, Tosteson TD, Lurie JD, et al.; SPORT Investigators. "Surgical versus nonsurgical therapy for lumbar spinal stenosis." N Engl J Med. 2008;358(8):794–810. — PubMed PMID: 18287602 · doi:10.1056/NEJMoa0707136
14. Devillé WL, van der Windt DA, Dzaferagić A, Bezemer PD, Bouter LM. "The test of Lasègue: systematic review of the accuracy in diagnosing herniated discs." Spine (Phila Pa 1976). 2000;25(9):1140–1147. — PubMed PMID: 10788860 · doi:10.1097/00007632-200005010-00016
15. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. "Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria." Arthritis Rheum. 2006;54(2):569–578. — PubMed PMID: 16447233 · doi:10.1002/art.21619
16. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. "The association between obesity and low back pain: a meta-analysis." Am J Epidemiol. 2010;171(2):135–154. — PubMed PMID: 20007994 · doi:10.1093/aje/kwp356
17. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, Lin CW. "Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial." Lancet. 2014;384(9954):1586–1596. — PubMed PMID: 25064594 · doi:10.1016/S0140-6736(14)60805-9
18. Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, Billot L, Shan S, Lin CC; OPAL Investigators Coordinators. "Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial." Lancet. 2023;402(10398):304–312. — PubMed PMID: 37392748 · doi:10.1016/S0140-6736(23)00404-X
19. GBD 2021 Low Back Pain Collaborators. "Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021." Lancet Rheumatol. 2023;5(6):e316–e329. — PubMed PMID: 37273833 · doi:10.1016/S2665-9913(23)00098-X

Search PubMed: Low Back Pain Treatment Evidence Lumbar Disc Herniation and Sciatica

Back to Table of Contents

Connections

• All Symptoms
• Joint Pain
• Numbness and Tingling
• Orthopedics
• Neurology
• Magnesium (muscle relaxation)
• Vitamin D3 (bone health)
• Low Back Pain
• Devil's Claw — the harpagoside-standardized root with Cochrane-reviewed evidence for chronic low-back pain.
• Shoulder Pain
• Neck Pain
• Discussed in depth on these pages: Chronic Low Back Pain — Evidence-Based Care · Axial Spondyloarthritis (nr-axSpA and Ankylosing Spondylitis)

Back to Table of Contents

Featured Videos

Back to Table of Contents